Gestational diabetes mellitus (GDM) poses significant risks to both mother and fetus. As healthcare professionals, it's imperative to stay informed about the latest strategies for effective management.
Early detection of GDM is crucial. The American Diabetes Association recommends universal screening between 24-28 weeks gestation using the 75g oral glucose tolerance test.
Initial management should involve lifestyle modification, including dietary changes and exercise. If blood glucose targets are not achieved, pharmacological treatment may be necessary. Insulin remains the first-line therapy, but oral hypoglycemic agents are gaining acceptance.
Postpartum follow-up is essential as women with GDM have a seven-fold increased risk of developing type 2 diabetes. Regular screening and lifestyle interventions can mitigate this risk.
Optimal management of GDM requires early detection, appropriate intervention, and vigilant follow-up. By staying updated with the latest guidelines, we can ensure the best possible outcomes for our patients.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation